Veterinary Medicines

Borrelym 3, Suspension for injection

Authorised
  • Borreliella afzelii, Inactivated
  • Borreliella garinii, Inactivated
  • Borreliella burgdorferi, Inactivated
Download as PDF

Product identification

Medicine name:
Merilym 3, Injektionssuspension für Hunde
Merilym 3 suspension injectable pour chiens
Borrelym 3, Suspension for injection
Active substance:
  • Borreliella afzelii, Inactivated
  • Borreliella garinii, Inactivated
  • Borreliella burgdorferi, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Borreliella afzelii, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Borreliella garinii, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Borreliella burgdorferi, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Glass Vial 50 x 1.0 millilitre(s)
  • Glass Vial 100 x 1.0 millilitre(s)
  • Glass Vial 20 x 1.0 millilitre(s)
  • Glass Vial 2 x 1.0 millilitre(s)
  • Glass Vial 10 x 1.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 344/13/02/1291
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0114/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/02/2023
Download
German (PDF)
Published on: 2/02/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 20/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."